Orbital Myositis

07/01/2012 - "A diagnosis of orbital myositis was made, and the patient experienced significant improvement with oral corticosteroids. "
03/01/1997 - "The authors conducted this study to evaluate their experience and the current status in the literature as to treatment of orbital myositis with corticosteroids and corticosteroid-sparing alternatives. "
01/01/2008 - "The clinical and radiological work up and the therapeutic test with corticosteroids were in favor of an inflammatory orbital myositis. "
09/01/2004 - "Two men with orbital myositis and mild discomfort, initially treated with corticosteroids, had asymptomatic intracranial disease 9 and 12 months after initial presentation. "
02/01/2001 - "Most cases of idiopathic orbital myositis require corticosteroids, but therapeutic alternatives to corticosteroids in refractory diseases are warranted."

07/01/2005 - "Treatment of orbital myositis with adalimumab (Humira)."
06/01/2011 - "Adalimumab for recurrent orbital myositis in Crohn's disease: report of a case with a 3-year follow-up."
01/01/2013 - "We report the use of adalimumab (Abbott, Canada, Inc.) for orbital myositis in a patient with Crohn's disease who discontinued infliximab (Janssen, Canada, Inc.) and review of the published literature. "
01/01/2013 - "Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature."
12/01/2012 - "The authors describe a 29-year-old woman who developed orbital myositis, in addition to anterior uveitis, sacroiliitis and peripheral arthritis, as a complication of an underlying HLA-B27 related spondyloarthropathy, which responded temporarily to corticosteroid therapy and more completely to adalimumab. "

01/01/2015 - "[Recurrent painful ophthalmoplegia revealing orbital myositis]."
12/01/2005 - "Relapsing-remitting painful ophthalmoplegia due to orbital myositis."
12/01/2005 - "We describe a woman with a long history of relapsing-remitting painful ophthalmoplegia in a seasonal pattern, due to an isolated orbital myositis that was--at our observation--classified in the context of the so-called SAPHO syndrome. "
01/01/2012 - "Painful ophthalmoplegia with simultaneous orbital myositis, optic and oculomotor nerve inflammation and trigeminal nucleus involvement in a patient with herpes zoster ophthalmicus."

09/01/2012 - "We describe the first case of bilateral, diffuse, orbital myositis associated with ulcerative colitis in a patient taking infliximab. "
12/01/2004 - "Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab."
01/01/2013 - "We report the use of adalimumab (Abbott, Canada, Inc.) for orbital myositis in a patient with Crohn's disease who discontinued infliximab (Janssen, Canada, Inc.) and review of the published literature. "
01/01/2013 - "Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature."
12/01/2004 - "To report results of treatment with a monoclonal antibody (infliximab) directed against tumor necrosis factor alpha in seven patients with chronic and difficult-to-control idiopathic orbital inflammation (orbital myositis). "

01/01/2003 - "Orbital myositis in a rheumatoid arthritis patient during etanercept treatment."
06/01/2006 - "Seventeen cases of inflammatory eye disease (uveitis, scleritis, orbital myositis) believed to be associated with etanercept therapy were found in the recent literature. "
02/01/2012 - "Forty-two cases of inflammatory eye diseases believed to be associated with the use of etanercept have been reported in the literature: 33 uveitis, 8 scleritis, 1 orbital myositis, concerning 16 patients with RA, 10 with juvenile idiopathic arthritis, 14 with ankylosing spondylitis, and 2 with psoriatic spondyloarthropathy. "

01/01/1993 - "Idiopathic orbital myositis: treatment with cyclosporin."
09/01/2009 - "To report on a case of idiopathic orbital myositis with scleritis that was effectively controlled with topical 0.05% cyclosporine A and to provide a review of the literature on the treatment of ocular myositis with scleritis. "

05/01/2015 - "Although almost any ocular adnexal tissue may be affected, there are several commoner recognizable patterns of IgG4-ROD: (1) sclerosing dacryoadenitis; 2) enlargement of orbital nerves (most commonly the infraorbital nerve) associated with orbital myositis and lacrimal gland disease, often in combination with paranasal sinus disease, eosinophilia, and systemic involvement; and 3) sclerosing orbital inflammation. "
03/01/2015 - "Although almost any ocular adnexal tissue may be affected, there are several more common recognizable patterns of IgG4-ROD: 1) sclerosing dacryoadenitis; 2) enlargement of orbital nerves (most commonly the infraorbital nerve) associated with orbital myositis and lacrimal gland disease, often in combination with paranasal sinus disease, eosinophilia, and systemic involvement; and 3) sclerosing orbital inflammation. "

06/01/2005 - "After a 1-year follow up, the orbital myositis remains unchanged and the digestive condition is satisfactory with a long-term mesalazine therapy. "

06/01/2012 - "Follow-up ophthalmologic exam revealed acute inflammatory right optic neuritis (visual acuity: 5/10, papillitis on fundus exam and papillary edema on fluorescein angiography) and persistence of left orbital myositis. "

01/01/2015 - "Orbital myositis: a side effect of interferon alpha 2b treatment."

02/01/2006 - "This case report underlines the importance of early and repeated monitoring of cardiac function, if orbital myositis is suspected, in order to consider cardiac transplantation, the only efficacious treatment of giant cell myocarditis, in time."

03/01/1997 - "Based on a long-term follow-up of six patients who received irradiation of 20 Gy, radiotherapy appears ineffective in stopping recurrent orbital myositis."

04/01/2005 - "The mild orbital myositis was treated with oral nonsteroidal anti-inflammatory drug therapy. "

09/01/2014 - "Successful "medical" orbital decompression with adjunctive rituximab for severe visual loss in IgG4-related orbital inflammatory disease with orbital myositis."